Comprehensive Analysis of RAPGEF2 for Predicting Prognosis and Immunotherapy Response in Patients with Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common tumor worldwide. Additionally, deletion of RAPGEF2 plays a critical role in CNV and related to tumor immune microenvironment, whereas the prognostic potential of RAPGEF2 in HCC patient needs to be explored. METHODS: We looked for pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qing, Hu, Yangzhi, Ma, Qinghui, Yang, Shanglin, Chen, Junpeng, Wen, Shunqian, Liao, Guanqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064514/
https://www.ncbi.nlm.nih.gov/pubmed/35518785
http://dx.doi.org/10.1155/2022/6560154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064514/
https://www.ncbi.nlm.nih.gov/pubmed/35518785
http://dx.doi.org/10.1155/2022/6560154

Ejemplares similares